The underlying circuit imbalance in major depression remains unknown and current therapies remain inadequate for a large group of patients. Discovery of the rapid antidepressant effects of ketamine--an NMDA receptor (NMDAR) antagonist--has linked the glutamatergic system to depression. Interestingly, dysfunction in the inhibitory GABAergic system has also been proposed to underlie depression and deficits linked to GABAergic neurons have been found with human imaging and in post-mortem material from depressed patients. Parvalbumin-expressing (PV) GABAergic interneurons regulate local circuit function through perisomatic inhibition and their activity is NMDAR-dependent, providing a possible link between NMDAR and the inhibitory system in the ...
Major depression is a mental disorder characterized by extreme low mood and anhedonia. Facing major ...
Accumulating evidence suggests dysfunction of the glutamate signaling system in major depressive dis...
Major depressive disorder (MDD) is associated with dysfunctional serotonergic and glutamatergic neur...
The underlying circuit imbalance in major depression remains unknown and current therapies remain in...
A growing body of evidence supports the idea that drugs targeting the glutamate system may represent...
Abstract A single, low dose of the NMDA receptor antagonist ketamine produces rapid antidepressant a...
BACKGROUND: Research studies suggest that glutamate dysfunction, in particular N-methyl-D-aspartate ...
Drugs targeting the glutamate N-methyl-d-aspartate receptor (NMDAR) may be efficacious for treating ...
Clinical studies consistently demonstrate that a single sub-psychomimetic dose of ketamine, an ionot...
AbstractBackgroundMajor depressive disorder is increasingly recognized to involve functional deficit...
Basic and clinical studies demonstrate that depression is associated with reduced size of brain regi...
Research studies suggest that glutamate dysfunction, in particular N-methyl-D-aspartate receptors (N...
Acute ketamine administration evokes rapid and sustained antidepressant effects in treatment-resista...
It has been suggested that a functional deficit in NMDA-receptors (NMDARs) on parvalbumin (PV)-posit...
Depression is a common mental disorder that is associated with memory dysfunction. Ketamine has rece...
Major depression is a mental disorder characterized by extreme low mood and anhedonia. Facing major ...
Accumulating evidence suggests dysfunction of the glutamate signaling system in major depressive dis...
Major depressive disorder (MDD) is associated with dysfunctional serotonergic and glutamatergic neur...
The underlying circuit imbalance in major depression remains unknown and current therapies remain in...
A growing body of evidence supports the idea that drugs targeting the glutamate system may represent...
Abstract A single, low dose of the NMDA receptor antagonist ketamine produces rapid antidepressant a...
BACKGROUND: Research studies suggest that glutamate dysfunction, in particular N-methyl-D-aspartate ...
Drugs targeting the glutamate N-methyl-d-aspartate receptor (NMDAR) may be efficacious for treating ...
Clinical studies consistently demonstrate that a single sub-psychomimetic dose of ketamine, an ionot...
AbstractBackgroundMajor depressive disorder is increasingly recognized to involve functional deficit...
Basic and clinical studies demonstrate that depression is associated with reduced size of brain regi...
Research studies suggest that glutamate dysfunction, in particular N-methyl-D-aspartate receptors (N...
Acute ketamine administration evokes rapid and sustained antidepressant effects in treatment-resista...
It has been suggested that a functional deficit in NMDA-receptors (NMDARs) on parvalbumin (PV)-posit...
Depression is a common mental disorder that is associated with memory dysfunction. Ketamine has rece...
Major depression is a mental disorder characterized by extreme low mood and anhedonia. Facing major ...
Accumulating evidence suggests dysfunction of the glutamate signaling system in major depressive dis...
Major depressive disorder (MDD) is associated with dysfunctional serotonergic and glutamatergic neur...